Archives

Mainz Biomed Appoints Steve Quinn as VP Business Development

Highly experienced diagnostics business development executive appointed to lead growth initiatives across international markets and drive international sales of ColoAlert at-home screening test for Colorectal CancerBERKELEY, Calif. and…

Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business

BERKELEY, Calif. and MAINZ, Germany, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced…